Surprise Me!
Novo Nordisk record profits with weight-loss-drug demand boost
2023-11-02
3
Dailymotion
Fiona Cincotta, Analyst from City Index talks with CGTN Europe on Novo Nordisk Q3 result.
Related Videos
Novo Nordisk reports Q1 profits o $3.65 BN as demand for weightloss drug soars
Ten Pharma Firms Form Non-profit to Speed Up New Drug Trials; InBalance Health Launches New Nutrition Bars; Novo Nordisk Ranks High on Carbon Disclosure Project - Health Minute for September 27, 2012
Novo Nordisk cuts supply of obesity drug Wegovy in the US due to surging demand
Novo Nordisk Shares Pop as New Obesity Drug Candidate Shows Impressive 13.1% Weight Loss in Early Trials
'Stop Ripping Us Off.' Senate Grills Novo Nordisk on High Prices of Weight Loss Drugs Wegovy and Ozempic in US.
Novo Nordisk earnings: sales of weight-loss drug Wegovy lower than expected
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
Novo Nordisk Raises Sales Growth Outlook Despite Profit Miss. CEO Predicts 'Attractive Growth' Amidst Competition and Regulation Shifts.
Novo Nordisk Boosts 2023 Outlook
Novo Nordisk Launches Wegovy Subscription Plans to Lower Costs and Boost Patient Retention
